Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Gynecol Oncol. 2012 Feb 12;125(2):451–457. doi: 10.1016/j.ygyno.2012.02.007

Fig. 3.

Fig. 3

Six1 immunohistochemistry with the cTerm antibody at 1:500 OV429 (Six1 mRNA=0 RSR, panel A), DOV13 (Six1 mRNA 0.25 RSR, panel B), CaOV3 (Six1 mRNA=0.42 RSR, panel C), OVCAR2 (Six1 mRNA 0.6 RSR, panel D), SKOV3 (Six1 mRNA= 1.0 RSR, panel E) and A2780 cell lines (Six1 mRNA=10.0 RSR, panel F). Insets for each panel are negative controls.